Xavier Chabin1, Ouarda Taghli-Lamallem1, Aurélien Mulliez2, Pierre Bordachar3, Frédéric Jean1, Emmanuel Futier4, Grégoire Massoullié1, Marius Andonache1, Géraud Souteyrand1, Sylvain Ploux3, Yves Boirie5, Ruddy Richard5, Bernard Citron1, Jean-R Lusson1, Thomas Godet4, Bruno Pereira2, Pascal Motreff1, Guillaume Clerfond1, Romain Eschalier6. 1. Université Clermont Auvergne, Cardio Vascular Interventional Therapy and Imaging (CaVITI), Image Science for Interventional Techniques (ISIT), UMR6284, and CHU Clermont-Ferrand, Cardiology Department, F-63003 Clermont-Ferrand, France. 2. CHU Clermont-Ferrand, Biostatistics Unit (Clinical Research and Innovation Direction), F-63000 Clermont-Ferrand, France. 3. Hôpital Cardiologique du Haut-Lévêque, CHU Bordeaux, Université Bordeaux, IHU LIRYC, Bordeaux, France. 4. Department of Perioperative Medicine, Anesthesiology and Critical Care Medicine, Estaing Hospital, University Hospital of Clermont-Ferrand and CNRS, Inserm U1103, GreD, Clermont-Ferrand, France. 5. Nutrition Department, CHU Clermont-Ferrand, F-63003 Clermont-Ferrand, France. 6. Université Clermont Auvergne, Cardio Vascular Interventional Therapy and Imaging (CaVITI), Image Science for Interventional Techniques (ISIT), UMR6284, and CHU Clermont-Ferrand, Cardiology Department, F-63003 Clermont-Ferrand, France. Electronic address: reschalier@chu-clermontferrand.fr.
Abstract
BACKGROUND & AIMS: There is an increase in the number of patients worldwide with cardiac implantable electronic devices (CIEDs). Current medical practice guidelines warn against performing bioimpedance analysis (BIA) in this group of patients in order to avoid any electromagnetic interference. These recommendations restrict using the BIA in patients undergoing heart failure or with nutrition disorders in whom BIA could be of major interest in detecting peripheral congestion and to help guide treatment. The present study was conducted to evaluate whether BIA caused electromagnetic interference in patients having CIEDs. METHODS: Patient enrollment was conducted during routine face-to-face consultations for scheduled CIEDs interrogations. Device battery voltage, lead impedance, pacing thresholds and device electrograms were recorded before and after each BIA measurement to detect any electromagnetic interference or oversensing. RESULTS: A total of 200 patients were enrolled. During BIA, no significant changes in battery voltage, lead impedance or pacing thresholds were detected, nor were there any inappropriate over- or undersensing observed in intracardiac electrograms. Furthermore, 6- and 12-month follow-up did not reveal any changes in CIEDs. CONCLUSIONS: This study shows no interference in patients equipped with CIEDs and suggests that BIA can be securely performed in these patients. Trial registered under the identifier NCT03045822.
BACKGROUND & AIMS: There is an increase in the number of patients worldwide with cardiac implantable electronic devices (CIEDs). Current medical practice guidelines warn against performing bioimpedance analysis (BIA) in this group of patients in order to avoid any electromagnetic interference. These recommendations restrict using the BIA in patients undergoing heart failure or with nutrition disorders in whom BIA could be of major interest in detecting peripheral congestion and to help guide treatment. The present study was conducted to evaluate whether BIA caused electromagnetic interference in patients having CIEDs. METHODS:Patient enrollment was conducted during routine face-to-face consultations for scheduled CIEDs interrogations. Device battery voltage, lead impedance, pacing thresholds and device electrograms were recorded before and after each BIA measurement to detect any electromagnetic interference or oversensing. RESULTS: A total of 200 patients were enrolled. During BIA, no significant changes in battery voltage, lead impedance or pacing thresholds were detected, nor were there any inappropriate over- or undersensing observed in intracardiac electrograms. Furthermore, 6- and 12-month follow-up did not reveal any changes in CIEDs. CONCLUSIONS: This study shows no interference in patients equipped with CIEDs and suggests that BIA can be securely performed in these patients. Trial registered under the identifier NCT03045822.
Authors: Fiorangelo De Ieso; Markus Reinhold Mutke; Noe Karl Brasier; Christina Janitha Raichle; Bettina Keller; Celine Sucker; Khaled Abdelhamid; Tiziano Bloch; Pamela Reissenberger; Ladina Schönenberg; Sandro Kevin Fischer; Jonas Saboz; Nora Weber; Sabine Schädelin; Nicole Bruni; Patrick R Wright; Jens Eckstein Journal: ESC Heart Fail Date: 2021-10-13
Authors: A Faragli; D Abawi; C Quinn; M Cvetkovic; T Schlabs; E Tahirovic; H-D Düngen; B Pieske; S Kelle; F Edelmann; Alessio Alogna Journal: Heart Fail Rev Date: 2021-09 Impact factor: 4.214